Yael Tobi Harris

Slower, flexible titration of semaglutide in 104 people with #T2D studied over 26 weeks improved adherence and reduced adverse events without compromising efficacy diabetesjournals.org/care/article/d…

Happening now! Presentation of the new @TheEndoSociety Clinical Practice Guideline on Primary Aldosteronism! Packed room on the last morning of #ENDO2025!

Entertaining and Informative Symposium on Updates in Management of Differentiated Thyroid Cancer with Drs Mike Tuttle, Julie Sosa and Trevor Angell! Looking forward to seeing the new ATA guidelines, just accepted for publication! #ENDO2025 @TheEndoSociety @JASosaMD @DoctorAngell

Great “Meet-The-Professor” session by @afreenshariffmd on Endocrine complications of non-immunotherapy cancer therapies, including Enfortumab vedotin, Capivasertib and Hepatic artery infusion pumps with dexamethasone! #ENDO2025 @TheEndoSociety

From #ENDO2025 @TheEndoSociety experts have encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today: endocrinenews.endocrine.org/endocrine-soci…

2) The Lancet Commission on the definition and diagnostic criteria of obesity, including limitations of the current definitions of obesity and introduction of 2 new categories: preclinical and clinical obesity; 3) Disparities in diagnosis of obesity and access to GLP1 tx 2/2

Excellent Plenary Session by Dr. Fatima Cody Stanford on 1) The Scientific Report of the 2025 Dietary Guidelines Advisory Committee, including recommendations for future research on culturally responsive interventions to improve diet; #ENDO2025 @TheEndoSociety @askdrfatima 1/2

Congratulations to Dr. Alice Levine on receiving the Endocrine Society’s Outstanding Educator Laureate Award! #ENDO2025 @TheEndoSociety

Aldosterone synthase inhibition for primary aldosteronism

Management of Diabetes and Hyperglycemia in the Hospital: A Systematic Review of Clinical Practice Guidelines ⁦@AmDiabetesAssn⁩ ⁦@DiabetesCareADA⁩ Turns out we need a consensus paper to agree on guidelines for glucose Rx in the hospital diabetesjournals.org/care/article/4…

Enjoying the debate on Active Surveillance of Low-Risk Differentiated Thyroid Cancer with Mike Tuttle and Markus Luster at #ENDO2025! @TheEndoSociety

Studies showing benefits of GLP1 agonists in type 1 diabetes are accumulating. Modest A1c reduction but impressive reductions in total daily insulin dose and weight reduction. #ENDO2025

Honored that Northwell Endocrinology was highlighted by ADA TV at the 2025 Annual Scientific Sessions! So proud of the incredible work that our Diabetes Teams and colleagues are doing! youtube.com/watch?v=Yy5uTH… @RifkaSchulmanMD @semiekang @HofNorthwellDOM @AmDiabetesAssn

The NIH has proposed making all Institute Directors political appointees which would inject politics into scientific decisions & bring instability to scientific leadership. Please object by clicking on the green “public comment” button at the top: federalregister.gov/documents/20... .

Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: multidisciplinary consensus statement bjanaesthesia.org/article/S0007-… @TheAACE @AmDiabetesAssn @ObesitySociety

@NorthwellHealth endocrinology team learning, sharing and presenting at #AACE2025 #WeAreAACE @TheAACE @HofNorthwellDOM @YTobiHarris @EndoNP_Tori @adamcadesky

Enjoyed speaking on #perioperative challenges of #SGLT2i and #GLP1RA @TheAACE #AACE2025 #WeAreAACE @HofNorthwellDOM @YTobiHarris

Really enjoyed making this podcast with @DianaMIsaacs and @natalie_bellini on bringing #T1D screening to clinical practice as well as discussing efforts at @NorthwellHealth @HofNorthwellDOM @YTobiHarris

Due to current HHS and NIH restructuring, the information provided on niddk.nih.gov is not being updated and may not be available in the future. Please refer to nih.gov.

Updates on perioperative cessation of #SGLT2i @YTobiHarris @HofNorthwellDOM bjanaesthesia.org/article/S0007-…